Trading in shares of Teva Pharmaceuticals was halted on the Tel Aviv Stock Exchange on word that the company would lay off a quarter of its work force over the next two years.
Up to that moment, the shares were down almost half a point on the day, but the stock has had serious losses in recent months, following losses in courts over patents.